跳至主要内容
临床试验/ACTRN12618001381279
ACTRN12618001381279撤回1 期

A single centre, double blind, randomised, parallel group, single dose signal study of R-107 in particpants with DSM-5 specific phobia, to spiders.

Douglas Pharmaceuticals Ltd0 个研究点目标入组 12 人开始时间: 2018年8月16日最近更新:
适应症

试验速览

阶段
1 期
状态
撤回
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 40 Years(—)
性别
All

入选标准

  • Able to provide informed consent; able and willing to comply with study requirements including clinic visits; male or female (not pregnant or lactating); aged 18-40 years; BMI 18-35kg/m2; diagnosed with DSM-5 specific phobia to spiders for at least 12 months; able to swallow tablets; score >95 on Fear of Spiders questionnaire (at screening visit)

排除标准

  • Clinically significant medical history or medications; clinically significant illness in last 30 days or febrile illness in last 5 days prior to Day 1; history of schizophrenia or other psychotic illness; currently taking benzodiazepines; prior exposure to ketamine; history of drug or alcohol abuse or dependency, including ketamine or it's excipients; clinically significant abnormal ECG or laboratory test result during screening; pregnant or breastfeeding female, or not using effective contraception; involvement in another clinical drug or device trial or less than 60 days since last participation; not having a GP or do not consent to GP being contacted; not able to understand information provided about the study, or not able to be compliant with required procedures; malignancy in last 5 years; employee/family member of sponsor, or study site.

研究者

相似试验

尚未招募
2 期
A single centre, double blind, randomised, parallel group study to explore the efficacy and tolerability of intranasal fluticasone propionate compared with placebo delivered by the OptiNose device in adult subjects with chronic rhinosinusitis.chronic rhinosinusitis10046304
NL-OMON30750OptiNose UK Ltd40
已完成
1 期
A single and multiple dose safety and tolerability study of oral ketamine in healthy volunteer and patients with a history of depression or anxiety.Mental Health - DepressionMental Health - AnxietyDepressionAnxiety
ACTRN12616001351404Zenith Technology Corp Ltd43
招募中
不适用
Clinical study of efficacy and safety of Chung A Won in Women’s patients with osteoporosisDiseases of the musculo-skeletal system and connective tissue
KCT0000594Cheonan Korean Medicine Hospital of Daejeon University106
已完成
3 期
A clinical study to test the effect of 2 product formulations against a control, on gingival conditions and plaque levels, in an experimental gingivitis model after 3 weeks of home use.
CTRI/2009/091/000626Smile Care Clinic Pvt Ltd100
进行中(未招募)
1 期
A single centre, randomised, single blind, parallel group single dose study to compare the speed of onset of ibuprofen gel, ibuprofen gel with levomenthol and diclofenac gel in the relief of pain from strains, sprains and sports injuriesPain of strains, sprains and sports injuriesMedDRA version: 18.1 Level: PT Classification code 10065016 Term: Post-traumatic pain System Organ Class: 10022117 - Injury, poisoning and procedural complications
EUCTR2015-005240-33-GBThe Mentholatum Company Ltd182
A single centre, double blind, randomised, parallel... | 临床试验